Astaxanthin Reduces Matrix Metalloproteinase Expression in Human Chondrocytes

Wei-Ping Chen,Yan Xiong,Yong-Xiang Shi,Peng-Fei Hu,Jia-Peng Bao,Li-Dong Wu
DOI: https://doi.org/10.1016/j.intimp.2013.12.007
IF: 5.714
2014-01-01
International Immunopharmacology
Abstract:Astaxanthin is a red carotenoid pigment which exerts multiple biological activities. However, little is known about the effects of astaxanthin on matrix metalloproteinases (MMPs) in OA. The present study investigated the effects of astaxanthin on MMPs in human chondrocytes. Human chondrocytes were pretreated with astaxanthin at 1, 10 or 50μM, then, cells were stimulated with IL-1β (10ng/ml) for 24h. MMP-1, MMP-3 and MMP-13 were observed. We found that astaxanthin reduced the expression of MMP-1, MMP-3 and MMP-13 as well as the phosphorylation of two mitogen-activated protein kinases (MAPK) (p38 and ERK1/2) in IL-1β-stimulated chondrocytes. Astaxanthin also blocked the IκB-α degradation. These results suggest that astaxanthin may be beneficial in the treatment of OA.
What problem does this paper attempt to address?